Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Lantheus Medical Imaging Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010996
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imaging. The company’s major products include ultrasound contrast agents, inhalable and injectable radiopharmaceutical imaging agents, and technetium-based generators. Its products are used to diagnose coronary artery disease, stroke, congestive heart failure, cancerous tumors and other diseases. Lantheus Medical develops its products using positron emission tomography and magnetic resonance imaging technologies. The company offers its products to nuclear physicians, internal medicine physicians, cardiologists, radiologists, technologists and sonographers. Lantheus Medical is headquartered in North Billerica, Massachusetts, the US.

Lantheus Medical Imaging Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lantheus Medical Imaging Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lantheus Medical Imaging Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lantheus Medical Imaging Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lantheus Medical Imaging Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Lantheus Medical Imaging Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lantheus Medical Imaging Inc, Medical Equipment, Deal Details 10
Partnerships 10
Lantheus Medical Imaging to Enter into Licensing Agreement with GE Healthcare 10
Lantheus Medical Imaging Extends License And Distribution Agreement With Fujifilm For Cardiolite And Neurolite 11
Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 12
Debt Offering 13
Lantheus Medical Imaging Completes Private Placement Of 9.75% Senior Unsecured Notes For US$150 Million 13
Lantheus Medical Imaging Inc – Key Competitors 14
Lantheus Medical Imaging Inc – Key Employees 15
Lantheus Medical Imaging Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Nov 02, 2017: Lantheus Holdings Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 Guidance 17
May 02, 2017: Lantheus Holdings Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance 18
Mar 30, 2017: Lantheus Announces Refinancing of its Debt Facility 19
Feb 21, 2017: Lantheus Holdings Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance 20
Nov 01, 2016: Lantheus Holdings Reports 2016 Third Quarter Financial Results 21
Aug 04, 2016: Lantheus Holdings Reports 2016 Second Quarter Financial Results 22
May 03, 2016: Lantheus Holdings Reports 2016 First Quarter Financial Results 23
Feb 22, 2016: Lantheus Holdings Reports 2015 Fourth Quarter and Full Year Financial Results; Provides 2016 Guidance 24
Corporate Communications 25
Jan 26, 2017: Lantheus Holdings Appoints New Member to its Board of Directors 25
Mar 08, 2016: Lantheus Holdings Announces Retirement of Director Dr. Patrick O’Neill; Appoints Two New Board Members 26
Product News 27
Jun 30, 2016: Lantheus Holdings Announces First Commercial Shipment of Xenon 133 Supplied by Institute for Radioelements 27
Other Significant Developments 28
Jan 13, 2016: Lantheus Announces Divestiture of Its Canadian Radiopharmacy Operations and Commencement of Long-Term Supply Agreement 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Lantheus Medical Imaging Inc, Medical Equipment, Key Facts, 2016 2
Lantheus Medical Imaging Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Lantheus Medical Imaging Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lantheus Medical Imaging Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lantheus Medical Imaging Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lantheus Medical Imaging Inc, Deals By Market, 2011 to YTD 2017 8
Lantheus Medical Imaging Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lantheus Medical Imaging to Enter into Licensing Agreement with GE Healthcare 10
Lantheus Medical Imaging Extends License And Distribution Agreement With Fujifilm For Cardiolite And Neurolite 11
Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 12
Lantheus Medical Imaging Completes Private Placement Of 9.75% Senior Unsecured Notes For US$150 Million 13
Lantheus Medical Imaging Inc, Key Competitors 14
Lantheus Medical Imaging Inc, Key Employees 15

★海外企業調査レポート[Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Konka Group Co., Ltd.
    Konka Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Konka Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SaskEnergy Incorporated:企業の戦略的SWOT分析
    SaskEnergy Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • BGI Genomics Co Ltd (300676):医療機器:M&Aディール及び事業提携情報
    Summary BGI Genomics Co Ltd (BGI) is a provider of sequencing services. The company offerings include DNA, RNA, non-invasive prenatal testing, newborn genetic screening, reproductive health screening, customized sequencing services and clinical exome sequencing services. It also offers clinical and …
  • Sojitz Corp (2768):企業の財務・戦略的SWOT分析
    Sojitz Corp (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Qatar Electricity & Water Co QPSC (QEWS):電力:M&Aディール及び事業提携情報
    Summary Qatar Electricity & Water Co QPSC (QEWC), formerly Qatar Electricity & Water Company QSC, is an electricity and water utility. It generates electricity and desalinates water. The company owns and operates various power generation and water desalination stations and substations primarily in Q …
  • PayPal Holdings Inc:企業の戦略・SWOT・財務分析
    PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Athabasca Oil Corp (ATH):石油・ガス:M&Aディール及び事業提携情報
    Summary Athabasca Oil Corp (Athabasca) is an upstream energy company which focuses on exploration, development and production of bitumen, light oil and liquids-rich natural gas from oil sands and related assets. The company employs multi-stage fracturing and horizontal drilling technology from uncon …
  • Gazprom Marketing & Trading Ltd:企業の戦略的SWOT分析
    Gazprom Marketing & Trading Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Evoke Pharma Inc (EVOK):企業の財務・戦略的SWOT分析
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases (GI). The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. Evoke Pharma also offe …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • eBay Inc:企業のM&A・事業提携・投資動向
    eBay Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's eBay Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Provectus Biopharmaceuticals Inc (PVCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務情報
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • KONE Corporation:企業のM&A・事業提携・投資動向
    KONE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KONE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Aviragen Therapeutics Inc (AVIR):企業の財務・戦略的SWOT分析
    Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • China Gezhouba Group Co Ltd (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ray Sigorta A.S.:企業の戦略・SWOT・財務情報
    Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report Summary Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Resverlogix Corp (RVX):企業の財務・戦略的SWOT分析
    Summary Resverlogix Corp (Resverlogix) is a biotechnology company which develops small molecule therapeutics for cardiovascular disease, diabetes mellitus, and chronic kidney disease. The company's lead product candidate include Apabetalone (RVX-208) is a first-in-class small molecule that inhibits …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆